The Middle East & Africa market was valued at USD 2.51 billion in 2024, with gradual growth supported by improved access to lab equipment and training.
The Middle East & Africa (MEA) laboratory equipment and disposables market is witnessing a phase of transition and growth, driven by increasing investments in healthcare infrastructure, rising demand for disease diagnostics, growing awareness about laboratory quality standards, and an emerging research and development ecosystem. Although the region still grapples with disparities in access to advanced laboratory resources, it presents vast potential, especially as countries prioritize modernization of their health systems and academic institutions. The market includes essential laboratory equipment such as microscopes, centrifuges, incubators, and diagnostic analyzers, alongside disposable items like pipette tips, test tubes, gloves, culture plates, and slides each playing a critical role in clinical diagnostics, environmental testing, academic research, and industrial quality control. In the Middle East, particularly in Gulf Cooperation Council (GCC) countries like the United Arab Emirates, Saudi Arabia, and Qatar, the market is driven by ambitious national visions for economic diversification, which place significant emphasis on healthcare and scientific innovation. These nations are investing heavily in medical infrastructure, public health laboratories, and research centers as part of long-term strategies such as Saudi Arabia’s Vision 2030 and the UAE’s National Innovation Strategy. Consequently, the demand for modern laboratory equipment and reliable disposables has surged, both in public sector initiatives and in private diagnostic chains. The establishment of new hospitals, universities, and research parks has brought with it a need for internationally compliant and technologically advanced laboratory tools that support high-throughput diagnostics, precision medicine, and bioscience innovation. According to the research report “Middle East & Africa Laboratory Equipment and Disposables Market Outlook, 2030” published by Bonafide Research, the Middle East & Africa Laboratory Equipment and Disposables market was valued at USD 2.51 Billion in 2024. Africa, while more fragmented in its growth trajectory, is gradually gaining momentum due to increased support from international donors, global health agencies, and regional governments. Countries such as South Africa, Kenya, Nigeria, and Egypt are leading the charge in laboratory modernization, often driven by urgent public health needs such as infectious disease surveillance, HIV/AIDS, tuberculosis, and malaria control. In recent years, the COVID-19 pandemic acted as a powerful catalyst, exposing critical gaps in diagnostic infrastructure and prompting accelerated investments in testing labs, mobile diagnostics, and biosafety facilities. These investments have left behind not just infrastructure but also institutional knowledge and greater public-private coordination elements that now support broader laboratory expansion across the continent. The research and academic segment in MEA is also gradually growing, especially in countries like South Africa and Egypt, where universities and public research institutions are expanding their capabilities in life sciences, agricultural research, and environmental monitoring. International collaborations and donor-led research funding are enabling access to advanced laboratory technologies, helping these countries participate in global scientific discourse. The adoption of Good Laboratory Practices (GLP), ISO certifications, and accreditation frameworks like SANAS (South African National Accreditation System) is also rising, promoting standardization and encouraging consistent procurement of quality lab equipment and consumables.
to Download this information in a PDF
A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.
Download Sample| By Product Type | Equipment(Centrifuges, Spectrophotometers & Microarray Equipment, Autoclaves & Sterilizers,Scopes,Incubators, Laminar Flow Hood,Lab Air Filtration Systems,Sonicators & Homogenizers, Micro Manipulation Systems,Others) | |
| Disposables(Gloves, Pipettes, Tubes,Tips,Masks, Cell Culture Consumables,Cell Imaging Consumables,Dishes, Cuvettes) | ||
| By End-User | Pharmaceuticals | |
| Hospitals | ||
| Academic/Research | ||
| Biotech | ||
| Industrial | ||
| MEA | United Arab Emirates | |
| Saudi Arabia | ||
| South Africa | ||
The region’s push for healthcare modernization and scientific infrastructure development is fueling high-value investments in advanced laboratory equipment to support diagnostics and research capabilities. In the Middle East & Africa (MEA), governments and healthcare systems are actively investing in building modern diagnostic and research capacities as part of broader national strategies to improve health outcomes and promote economic diversification. This drive is particularly visible in countries like Saudi Arabia, the UAE, South Africa, and Egypt, where both public and private sectors are upgrading laboratories with automated, high-precision instruments such as analyzers, PCR machines, centrifuges, and biosafety cabinets. The need for durable and efficient lab operations especially in response to infectious disease control, chronic illness management, and medical tourism is placing strong emphasis on equipment procurement. In addition, partnerships with international research organizations and growing local production of pharmaceuticals are increasing the demand for sophisticated laboratory setups. While consumables are critical to day-to-day functions, the bulk of institutional funding is directed toward acquiring long-term, capital-intensive equipment that can enable high-throughput testing, improve lab accuracy, and align with international regulatory standards making equipment the leading segment in the regional lab market. The rising pharmaceutical production and quality control demands in MEA are making the pharmaceutical industry the largest consumer of laboratory tools in the region. Pharmaceuticals are driving the growth of laboratory equipment and disposables usage in the Middle East & Africa due to a regional push to enhance local drug manufacturing, regulatory compliance, and public health resilience. Countries such as Saudi Arabia, Egypt, and South Africa are increasing domestic pharmaceutical production through public-private partnerships, regulatory reforms, and incentives to reduce reliance on imports and meet rising healthcare needs. These efforts require well-equipped laboratories for formulation, stability testing, microbiology, and quality assurance, all of which depend on high-performance instruments and sterile, single-use consumables. Furthermore, the increasing involvement of MEA countries in clinical trials and biosimilar development amplifies the demand for precision lab operations. The pharmaceutical sector also plays a key role in pandemic preparedness and vaccine manufacturing, reinforcing the need for advanced lab infrastructure. As a result, pharmaceutical laboratories continue to lead demand for both equipment and disposables due to their comprehensive and ongoing need for validated testing environments and regulatory adherence.
to Download this information in a PDF
Saudi Arabia leads the regional market due to its large-scale investments in healthcare transformation, biopharma development, and laboratory infrastructure under Vision 2030. Saudi Arabia is at the forefront of the Middle East & Africa laboratory equipment and disposables market, driven by its ambitious Vision 2030 plan, which prioritizes healthcare innovation, scientific research, and domestic pharmaceutical manufacturing. The country is heavily investing in expanding hospitals, clinical laboratories, research institutions, and biotechnology parks, which in turn require high-end laboratory instruments and a consistent supply of compliant disposables. With a clear mandate to enhance disease diagnostics, promote medical research, and attract global healthcare partnerships, Saudi Arabia is equipping its labs with cutting-edge technologies ranging from molecular diagnostic platforms to robotic analyzers. Additionally, the government's emphasis on health security, local vaccine production, and biosimilar development has accelerated demand for laboratory setups that meet international quality and regulatory standards. These investments are supported by favorable policy environments, international collaborations, and rising private healthcare activity, positioning Saudi Arabia as the most advanced and fastest-growing market for laboratory solutions in the MEA region.
to Download this information in a PDF

We are friendly and approachable, give us a call.